From Proteomics to Prescription—The Search for COPD Biomarkers

REFERENCES

• Franciosi L G, Page C P, Celli B R, Cazzola M, Walker M J, Danhof M, Rabe K F, la Pasqua O E. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006; 19: 189–199
   PubMed Web of Science ®Google Scholar
• Hurst J R, Perera W R, Wilkinson T M, Donaldson G C, Wedzicha J A. Exacerbation of chronic obstructive pulmonary disease: pan-airway and systemic inflammatory indices. Proc Amer Thorac Soc 2006; 3: 481–482
   PubMedGoogle Scholar
• Wielders P L, Dekhuijzen P N. Disease monitoring in chronic obstructive pulmonary disease: is there a role for biomarkers?. Eur Respir J 1997; 10: 2443–2445
   PubMed Web of Science ®Google Scholar
• Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD 2004; 1: 155–164
   PubMedGoogle Scholar
• Casado B, Iadarola P, Luisetti M, Kussmann M. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev Proteom 2008; 5: 693–704
   PubMed Web of Science ®Google Scholar
• Barnes P J, Stockley R A. COPD: current therapeutic interventions and future approaches. Eur Respir J 2005; 25: 1084–1106
   PubMed Web of Science ®Google Scholar
• Pinto-Plata V, Toso J, Lee K, Bilello J, Mullerova H, De S M, Vessey R, Celli B. Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters. Proc Amer Thorac Soc 2006; 3: 465–466
   PubMedGoogle Scholar
• Merkel D, Rist W, Seither P, Weith A, Lenter M C. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 2005; 5: 2972–2980
   PubMed Web of Science ®Google Scholar
• Tzortzaki E G, Lambiri I, Vlachaki E, Siafakas N M. Biomarkers in COPD. Curr Med Chem 2007; 14: 1037–1048
   PubMed Web of Science ®Google Scholar
• Bowler R P, Ellison M C, Reisdorph N. Proteomics in pulmonary medicine. Chest 2006; 130: 567–574
   PubMed Web of Science ®Google Scholar
• Ashitani J, Mukae H, Arimura Y, Matsukura S. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Intern Med 2002; 41: 181–185
   PubMed Web of Science ®Google Scholar
• Sunderland T, Gur R E, Arnold S E. The use of biomarkers in the elderly: current and future challenges. Biol Psych 2005; 58: 272–276
   PubMed Web of Science ®Google Scholar
• Lakhan S E. Schizophrenia proteomics: biomarkers on the path to laboratory medicine?. Diagn Pathol 2006; 1: 11
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working G Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89–95
   PubMed Web of Science ®Google Scholar
• Pascal L E, True L D, Campbell D S, Deutsch E W, Risk M, Coleman I M, Eichner L J, Nelson P S, Liu A Y. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genom 2008; 9: 246
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy T F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001; 14: 336–363
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434–1440
   PubMed Web of Science ®Google Scholar
• Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–1504
   PubMed Web of Science ®Google Scholar
• Kharitonov S A, Barnes P J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002; 7: 1–32
   PubMed Web of Science ®Google Scholar
• Jeffery P K, Laitinen A, Venge P. Biopsy markers of airway inflammation and remodelling. Respir Med 2000; 94(Suppl F)S9–15
   PubMedGoogle Scholar
• Jones P W, Agusti A G. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 822–832
   PubMed Web of Science ®Google Scholar
• Cazzola M, MacNee W, Martinez F J, Rabe K F, Franciosi L G, Barnes P J, Brusasco V, Burge P S, Calverley P M, Celli B R, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416–469
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Wouters E F, Creutzberg E C, Schols A M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006; 61: 17–22
   PubMed Web of Science ®Google Scholar
• Man S F, Xing L, Connett J E, Anthonisen N R, Wise R A, Tashkin D P, Zhang X, Vessey R, Walker T G, Celli B R, et al. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?. Eur Respir J 2008; 32: 1451–1457
   PubMed Web of Science ®Google Scholar
• Fogarty A W, Jones S, Britton J R, Lewis S A, McKeever T M. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007; 62: 515–520
   PubMed Web of Science ®Google Scholar
• Donaldson G C, Seemungal T A, Patel I S, Bhowmik A, Wilkinson T M, Hurst J R, Maccallum P K, Wedzicha J A. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995–2004
   PubMed Web of Science ®Google Scholar
• Roth M. Pathogenesis of COPD. Part III. Inflammation in COPD. Int J Tuberc Lung Dis 2008; 12: 375–380
   PubMed Web of Science ®Google Scholar
• Kranenburg A R, Willems-Widyastuti A, Moori W J, Sterk P J, Alagappan V K, de Boer W I, Sharma H S. Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol 2006; 126: 725–735
   PubMed Web of Science ®Google Scholar
• Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653
   PubMed Web of Science ®Google Scholar
• Higashimoto Y, Yamagata Y, Iwata T, Okada M, Ishiguchi T, Sato H, Masuda M, Itoh H. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Respir J 2005; 25: 885–890
   PubMed Web of Science ®Google Scholar
• Szoltysik E, Kucharz E J. Serum markers of collagen metabolism in patients with diseases of the respiratory system. Rom J Intern Med 1993; 31: 119–122
   PubMedGoogle Scholar
• Celedon J C, Lange C, Raby B A, Litonjua A A, Palmer L J, Demeo D L, Reilly J J, Kwiatkowski D J, Chapman H A, Laird N, et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004; 13: 1649–1656
   PubMed Web of Science ®Google Scholar
• Ito M, Hanaoka M, Droma Y, Hatayama O, Sato E, Katsuyama Y, Fujimoto K, Ota M. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Intern Med 2008; 47: 1387–1394
   PubMed Web of Science ®Google Scholar
• Sin D D, Man S F. Biomarkers in COPD: are we there yet?. Chest 2008; 133: 1296–1298
   PubMed Web of Science ®Google Scholar
• Erin E M, Jenkins G R, Kon O M, Zacharasiewicz A S, Nicholson G C, Neighbour H, Tennant R C, Tan A J, Leaker B R, Bush A, et al. Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants. Am J Respir Crit Care Med 2008; 177: 132–141
   PubMed Web of Science ®Google Scholar
• Noel-Georis I, Bernard A, Falmagne P, Wattiez R. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 771: 221–236
   PubMed Web of Science ®Google Scholar
• Plymoth A, Yang Z, Lofdahl C G, Ekberg-Jansson A, Dahlback M, Fehniger T E, Marko-Varga G, Hancock W S. Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry. Clin Chem 2006; 52: 671–679
   PubMed Web of Science ®Google Scholar
• Nicholas B, Skipp P, Mould R, Rennard S, Davies D E, O'Connor C D, Djukanovic R. Shotgun proteomic analysis of human-induced sputum. Proteomics 2006; 6: 4390–4401
   PubMed Web of Science ®Google Scholar
• Millea K M, Krull I S, Chakraborty A B, Gebler J C, Berger S J. Comparative profiling of human saliva by intact protein LC/ESI-TOF mass spectrometry. Biochim Biophys Acta 2007; 1774: 897–906
   PubMed Web of Science ®Google Scholar
• Hu S, Xie Y, Ramachandran P, Ogorzalek Loo R R, Li Y, Loo J A, Wong D T. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005; 5: 1714–1728
   PubMed Web of Science ®Google Scholar
• Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo R R, Loo J R, Wong D T. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007; 4: 55–64
   PubMedGoogle Scholar
• Hardt M, Thomas L R, Dixon S E, Newport G, Agabian N, Prakobphol A, Hall S C, Witkowska H E, Fisher S J. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 2005; 44: 2885–2899
   PubMed Web of Science ®Google Scholar
• Huang C M. Comparative proteomic analysis of human whole saliva. Arch Oral Biol 2004; 49: 951–962
   PubMed Web of Science ®Google Scholar
• Xie H, Rhodus N L, Griffin R J, Carlis J V, Griffin T J. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 2005; 4: 1826–1830
   PubMed Web of Science ®Google Scholar
• Amado F M, Vitorino R M, Domingues P M, Lobo M J, Duarte J A. Analysis of the human saliva proteome. Expert Rev Proteomics 2005; 2: 521–539
   PubMed Web of Science ®Google Scholar
• Kipnis E, Hansen K, Sawa T, Moriyama K, Zurawel A, Ishizaka A, Wiener-Kronish J. Proteomic analysis of undiluted lung epithelial lining fluid. Chest 2008; 134: 338–345
   PubMed Web of Science ®Google Scholar
• Debat H, Eloit C, Blon F, Sarazin B, Henry C, Huet J C, Trotier D, Pernollet J C. Identification of human olfactory cleft mucus proteins using proteomic analysis. J Proteome Res 2007; 6: 1985–1996
   PubMed Web of Science ®Google Scholar
• Ghafouri B, Irander K, Lindbom J, Tagesson C, Lindahl M. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J Proteome Res 2006; 5: 330–338
   PubMed Web of Science ®Google Scholar
• Casado B, Pannell L K, Viglio S, Iadarola P, Baraniuk J N. Analysis of the sinusitis nasal lavage fluid proteome using capillary liquid chromatography interfaced to electrospray ionization-quadrupole time of flight-tandem mass spectrometry. Electrophoresis 2004; 25: 1386–1393
   PubMed Web of Science ®Google Scholar
• Casado B, Pannell L K, Iadarola P, Baraniuk J N. Identification of human nasal mucous proteins using proteomics. Proteomics 2005; 5: 2949–2959
   PubMed Web of Science ®Google Scholar
• Bryborn M, Adner M, Cardell L O. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir Res 2005; 6: 118
   PubMed Web of Science ®Google Scholar
• Malmstrom J, Larsen K, Malmstrom L, Tufvesson E, Parker K, Marchese J, Williamson B, Patterson D, Martin S, Juhasz P, et al. Nanocapillary liquid chromatography interfaced to tandem matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry: mapping the nuclear proteome of human fibroblasts. Electrophoresis 2003; 24: 3806–3814
   PubMed Web of Science ®Google Scholar
• Malmstrom J, Larsen K, Malmstrom L, Tufvesson E, Parker K, Marchese J, Williamson B, Hattan S, Patterson D, Martin S, et al. Proteome annotations and identifications of the human pulmonary fibroblast. J Proteome Res 2004; 3: 525–537
   PubMed Web of Science ®Google Scholar
• Bogatkevich G S, Ludwicka-Bradley A, Singleton C B, Bethard J R, Silver R M. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol 2008; 295: L603–L611
   PubMed Web of Science ®Google Scholar
• Kelsen S G, Duan X, Ji R, Perez O, Liu C, Merali S. Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol 2008; 38: 541–550
   PubMed Web of Science ®Google Scholar
• Li C, Zhan X, Li M, Wu X, Li F, Li J, Xiao Z, Chen Z, Feng X, Chen P, et al. Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues. Genomics Proteomics Bioinformatics 2003; 1: 58–67
   PubMedGoogle Scholar
• Zhao H, Adler K B, Bai C, Tang F, Wang X. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases. J Proteome Res 2006; 5: 743–755
   PubMed Web of Science ®Google Scholar
• Jin M, Opalek J M, Marsh C B, Wu H M. Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am J Respir Cell Mol Biol 2004; 31: 322–329
   PubMed Web of Science ®Google Scholar
• Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson A S, Silvestrini R, Smallwood D, Vlahos R, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 269–278
   PubMed Web of Science ®Google Scholar
• Bai Y, Galetskiy D, Damoc E, Paschen C, Liu Z, Griese M, Liu S, Przybylski M. High resolution mass spectrometric alveolar proteomics: identification of surfactant protein SP-A and SP-D modifications in proteinosis and cystic fibrosis patients. Proteomics 2004; 4: 2300–2309
   PubMed Web of Science ®Google Scholar
• Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllarniemi M, Kinnula V L. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 2008; 7: 5125–5132
   PubMed Web of Science ®Google Scholar
• Casado B, Iadarola P, Pannell L K, Luisetti M, Corsico A, Ansaldo E, Ferrarotti I, Boschetto P, Baraniuk J N. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res 2007; 6: 4615–4623
   PubMed Web of Science ®Google Scholar
• Reynolds S D, Reynolds P R, Pryhuber G S, Finder J D, Stripp B R. Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways. Am J Respir Crit Care Med 2002; 166: 1498–1509
   PubMed Web of Science ®Google Scholar
• Gray R D, MacGregor G, Noble D, Imrie M, Dewar M, Boyd A C, Innes J A, Porteous D J, Greening A P. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med 2008; 178: 444–452
   PubMed Web of Science ®Google Scholar
• Ekblad L, Baldetorp B, Ferno M, Olsson H, Bratt C. In-source decay causes artifacts in SELDI-TOF MS spectra. J Proteome Res 2007; 6: 1609–1614
   PubMed Web of Science ®Google Scholar
• Semmes O J, Feng Z, Adam B L, Banez L L, Bigbee W L, Campos D, Cazares L H, Chan D W, Grizzle W E, Izbicka E, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005; 51: 102–112
   PubMed Web of Science ®Google Scholar
• Lorenz E, Muhlebach M S, Tessier P A, Alexis N E, Duncan H R, Seeds M C, Peden D B, Meredith W. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 2008; 102: 567–573
   PubMed Web of Science ®Google Scholar
• Uhlen M. Affinity as a tool in life science. Biotechniques 2008; 44: 649–654
   PubMed Web of Science ®Google Scholar
• Hober S, Uhlen M. Human protein atlas and the use of microarray technologies. Curr Opin Biotechnol 2008; 19: 30–35
   PubMed Web of Science ®Google Scholar
• Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004; 4: 1175–1186
   PubMed Web of Science ®Google Scholar
• Anderson L, Hunter C L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006; 5: 573–588
   PubMed Web of Science ®Google Scholar
• McDonnell L A, Heeren R M. Imaging mass spectrometry. Mass Spectrom Rev 2007; 26: 606–643
   PubMed Web of Science ®Google Scholar
• Khatib-Shahidi S, Andersson M, Herman J L, Gillespie T A, Caprioli R M. Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal Chem 2006; 78: 6448–6456
   PubMed Web of Science ®Google Scholar
• Andersson M, Groseclose M R, Deutch A Y, Caprioli R M. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Meth 2008; 5: 101–108
   PubMed Web of Science ®Google Scholar
• Sinha T K, Khatib-Shahidi S, Yankeelov T E, Mapara K, Ehtesham M, Cornett D S, Dawant B M, Caprioli R M, Gore J C. Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Meth 2008; 5: 57–59
   PubMed Web of Science ®Google Scholar
• Bachi A, Bonaldi T. Quantitative proteomics as a new piece of the systems biology puzzle. J Proteomics 2008; 71: 357–367
   PubMed Web of Science ®Google Scholar
• Preisinger C, von K A, Matallanas D, Kolch W. Proteomics and phosphoproteomics for the mapping of cellular signalling networks. Proteomics 2008; 8: 4402–4415
   PubMed Web of Science ®Google Scholar